The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christopher R. Chapple

Sheffield Teaching Hospitals NHS Trust

Royal Hallamshire Hospital

Glossop Road

Sheffield S10 2JF

UK. Electronic address:

[email]@sheffield.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Electronic address:. 2005 - 2012
  • The Royal Hallamshire Hospital, Sheffield, UK. 1998 - 2010
  • Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Hallam University, Sheffield, UK. 2006
  • Section of Reconstruction, Urodynamics and Female Urology, Department of Urology, The Royal Hallamshire Hospital, UK. 2005

References

  1. β3-Agonist Therapy: A New Advance in the Management of Overactive Bladder? Chapple, C.R. Eur. Urol. (2012) [Pubmed]
  2. Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration. Chapple, C.R., Herschorn, S., Abrams, P., Wang, J.T., Brodsky, M., Guan, Z. BJU Int. (2010) [Pubmed]
  3. Listening to the patient: a flexible approach to the use of antimuscarinic agents in overactive bladder syndrome. Chapple, C.R., Rosenberg, M.T., Brenes, F.J. BJU Int. (2009) [Pubmed]
  4. Lower urinary tract symptoms: new perspectives on prevalence, burden and comorbidities. Introduction. Chapple, C.R., Kaplan, S.A. BJU Int. (2009) [Pubmed]
  5. The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?. Chapple, C., De Ridder, D. BJU Int. (2009) [Pubmed]
  6. Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple, C.R., Wein, A.J., Abrams, P., Dmochowski, R.R., Giuliano, F., Kaplan, S.A., McVary, K.T., Roehrborn, C.G. Eur. Urol. (2008) [Pubmed]
  7. Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg. Chapple, C.R., Fianu-Jonsson, A., Indig, M., Khullar, V., Rosa, J., Scarpa, R.M., Mistry, A., Wright, D.M., Bolodeoku, J. Eur. Urol. (2007) [Pubmed]
  8. Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy. Chapple, C.R., Brubaker, L., Haab, F., van Kerrebroeck, P., Robinson, D. Int. Urogynecol. J. Pelvic. Floor. Dysfunct (2007) [Pubmed]
  9. Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder. Chapple, C.R. Expert. Opin. Pharmacother (2006) [Pubmed]
  10. Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004). Chapple, C.R., Patroneva, A., Raines, S.R. Eur. Urol. (2006) [Pubmed]
  11. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Chapple, C.R., Cardozo, L., Steers, W.D., Govier, F.E. Int. J. Clin. Pract. (2006) [Pubmed]
  12. Developments in pharmacological therapy for the overactive bladder. Chapple, C.R., Gormley, E.A. BJU Int. (2006) [Pubmed]
  13. Vesico-vaginal fistula. Chapple, C., Turner-Warwick, R. BJU Int. (2005) [Pubmed]
  14. A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence. Chapple, C.R., Wein, A.J., Artibani, W., Brubaker, L., Haab, F., Heesakkers, J.P., Lightner, D. BJU Int. (2005) [Pubmed]
  15. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. Chapple, C.R., Artibani, W., Cardozo, L.D., Castro-Diaz, D., Craggs, M., Haab, F., Khullar, V., Versi, E. BJU Int. (2005) [Pubmed]
  16. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Chapple, C., Khullar, V., Gabriel, Z., Dooley, J.A. Eur. Urol. (2005) [Pubmed]
  17. Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow. Chapple, C.R., Abrams, P. Eur. Urol. (2005) [Pubmed]
  18. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Chapple, C.R., Haab, F., Cervigni, M., Dannecker, C., Fianu-Jonasson, A., Sultan, A.H. Eur. Urol. (2005) [Pubmed]
  19. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Chapple, C.R., Martinez-Garcia, R., Selvaggi, L., Toozs-Hobson, P., Warnack, W., Drogendijk, T., Wright, D.M., Bolodeoku, J. Eur. Urol. (2005) [Pubmed]
  20. Stress incontinence injection therapy: what is best for our patients?. Chapple, C.R., Wein, A.J., Brubaker, L., Dmochowski, R., Pons, M.E., Haab, F., Hill, S. Eur. Urol. (2005) [Pubmed]
  21. Serotonin-induced potentiation of cholinergic responses to electrical field stimulation in normal and neurogenic overactive human detrusor muscle. Chapple, C.R., Radley, S.C., Martin, S.W., Sellers, D.J., Chess-Williams, R. BJU Int. (2004) [Pubmed]
  22. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. Chapple, C.R. BJU Int. (2004) [Pubmed]
  23. Alpha adrenoceptor antagonists in the year 2000: is there anything new?. Chapple, C.R. Curr. Opin. Urol (2001) [Pubmed]
  24. Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practices. Chapple, C.R. Eur. Urol. (2001) [Pubmed]
  25. Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: design and implementation. Chapple, C.R. Eur. Urol. (2001) [Pubmed]
  26. Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks. Chapple, C.R. Eur. Urol. (2000) [Pubmed]
  27. BHP Disease Management. Introduction and concluding remarks. Chapple, C.R. Eur. Urol. (1999) [Pubmed]
  28. Latest developments in the field of neurotransmitters. Chapple, C., Chess-Williams, R. Eur. Urol. (1998) [Pubmed]
  29. Medical therapy and quality of life. Chapple, C.R. Eur. Urol. (1998) [Pubmed]
 
WikiGenes - Universities